Current Report Filing (8-k)
July 20 2017 - 1:09PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
July
14, 2017 (July 20, 2017)
Commission
File #:
000-53723
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
(State
or other jurisdiction of incorporation)
30-0791746
(IRS
Employer Identification Number)
39
Old Ridgebury Road
Danbury,
CT 06180
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
ITEM
8.01 – OTHER EVENTS.
On
July 14, 2017, Tauriga Sciences, Inc. (the “Company”) agreed to settle the outstanding litigation brought by Crystal
Research Associates, LLC (“Crystal Research”) against the Company. The terms of the settlement are set forth below.
An
aggregate of $31,450 in cash will be paid by the Company to Crystal Research as follows: (i) $8,000 within two days of July 14,
2017 and (ii) $3,350 on the 15
th
day of each month beginning on August 15, 2017 and continuing until February 15, 2018.
Additionally, the Company agreed to grant Crystal Research 11,000,000 shares of the Company’s common stock (the “Settlement
Shares”). The Settlement Shares will be “restricted securities” as defined by Rule 144 of the Securities Act
of 1933, as amended.
As
of the date of this Current Report on Form 8-K, the Company has paid to Crystal Research the $8,000 and the first two monthly
payments of $3,350. In the event the Company defaults on the payment terms, the Company shall owe to Crystal Research $48,000
(less any payments previously made) plus the value of the Settlement Shares as of the date of issuance.
As
disclosed in the Annual Report on Form 10-K filed with the Securities and Exchange Commission by the Company on July 7, 2017,
Crystal Research filed an action against the Company in Supreme Court of the State of New York, County of New York (Index No.
161962/2015), on December 9, 2015 alleging that the Company owed to Crystal Research a total of $48,000. This money that Crystal
Research alleged was owed is related to a March 13, 2014 “Public Relations Services” contract entered into by the
Company’s previous Chief Executive Officer, Dr. Stella Sung.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
July 20, 2017
|
|
|
|
|
|
|
TAURIGA SCIENCES, INC.
|
|
|
|
|
By:
|
/s/
Seth M. Shaw
|
|
|
Seth
M. Shaw
|
|
|
Chief
Executive Officer
|
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024